Barclays’s HUTCHMED HCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,720
| Closed | -$42.8K | – | 5413 |
|
|
2025
Q3 | $42.8K | Buy |
2,720
+278
| +11% | +$4.58K | ﹤0.01% | 4806 |
|
|
2025
Q2 | $36.8K | Sell |
2,442
-4,067
| -62% | -$59.4K | ﹤0.01% | 4751 |
|
|
2025
Q1 | $97.9K | Buy |
6,509
+4,102
| +170% | +$60.7K | ﹤0.01% | 4418 |
|
|
2024
Q4 | $34.7K | Buy |
2,407
+2,255
| +1,484% | +$40.3K | ﹤0.01% | 4834 |
|
|
2024
Q3 | $2.97K | Buy |
+152
| New | +$2.75K | ﹤0.01% | 5060 |
|
|
2024
Q2 | – | Sell |
-30,631
| Closed | -$515K | – | 5048 |
|
|
2024
Q1 | $515K | Sell |
30,631
-15,287
| -33% | -$232K | ﹤0.01% | 3573 |
|
|
2023
Q4 | $832K | Hold |
45,918
| – | – | ﹤0.01% | 3579 |
|
|
2023
Q3 | $778K | Hold |
45,918
| – | – | ﹤0.01% | 2507 |
|
|
2023
Q2 | $551K | Hold |
45,918
| – | – | ﹤0.01% | 2697 |
|
|
2023
Q1 | $598K | Buy |
45,918
+35,883
| +358% | +$588K | ﹤0.01% | 3142 |
|
|
2022
Q4 | $148K | Sell |
10,035
-60,165
| -86% | -$658K | ﹤0.01% | 4005 |
|
|
2022
Q3 | $622K | Buy |
70,200
+11,300
| +19% | +$142K | ﹤0.01% | 2563 |
|
|
2022
Q2 | $744K | Sell |
58,900
-106,100
| -64% | -$1.35M | ﹤0.01% | 2562 |
|
|
2022
Q1 | $3.12M | Buy |
165,000
+100,400
| +155% | +$2.56M | ﹤0.01% | 1529 |
|
|
2021
Q4 | $2.27M | Sell |
64,600
-609
| -0.9% | -$19.8K | ﹤0.01% | 2313 |
|
|
2021
Q3 | $2.39M | Sell |
65,209
-47,177
| -42% | -$1.86M | ﹤0.01% | 2195 |
|
|
2021
Q2 | $4.41M | Buy |
112,386
+65,892
| +142% | +$1.9M | ﹤0.01% | 1673 |
|
|
2021
Q1 | $1.31M | Sell |
46,494
-33,142
| -42% | -$1.06M | ﹤0.01% | 2598 |
|
|
2020
Q4 | $2.55M | Buy |
79,636
+53,500
| +205% | +$1.64M | ﹤0.01% | 2051 |
|
|
2020
Q3 | $844K | Buy |
26,136
+11,300
| +76% | +$352K | ﹤0.01% | 2829 |
|
|
2020
Q2 | $409K | Buy |
14,836
+1,836
| +14% | +$39.8K | ﹤0.01% | 3504 |
|
|
2020
Q1 | $232K | Sell |
13,000
-21,061
| -62% | -$508K | ﹤0.01% | 4175 |
|
|
2019
Q4 | $854K | Buy |
34,061
+16,917
| +99% | +$370K | ﹤0.01% | 3815 |
|
|
2019
Q3 | $305K | Buy |
17,144
+6,692
| +64% | +$139K | ﹤0.01% | 4648 |
|
|
2019
Q2 | $230K | Sell |
10,452
-5,498
| -34% | -$157K | ﹤0.01% | 4986 |
|
|
2019
Q1 | $488K | Sell |
15,950
-19,004
| -54% | -$474K | ﹤0.01% | 4150 |
|
|
2018
Q4 | $807K | Buy |
+34,954
| New | +$1.09M | ﹤0.01% | 3327 |
|
Other funds holding HCM
AG
MGP
XC
Barclays's HCM Position: Q4 2025 in Review
Barclays sold out of HUTCHMED (HCM) in Q4 2025, closing a stake of 2,720 shares — an estimated $42.8K sold.
Barclays first reported a position in HCM in Q4 2018 and held it in 27 quarters. The position peaked at $4.41M in Q2 2021. 50 funds tracked by Wall St. Rank hold HCM as of Q4 2025.
- Barclays reported no remaining HUTCHMED position as of Q4 2025 after selling out during the quarter.
- Barclays sold 2,720 HUTCHMED shares in Q4 2025, an estimated $42.8K.
- Barclays first reported a position in HUTCHMED in Q4 2018 and held it in 27 quarters.
- Barclays's HUTCHMED position peaked at $4.41M in Q2 2021.
- 50 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2025.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.